OMX Copenhagen PI
1.397,40
PKT
+17,21
PKT
+1,25
%
Werbung
Analysen zu OMX Copenhagen PI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 20.09.19 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 19.09.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 18.09.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 13.09.19 | Novo Nordisk Neutral | Merrill Lynch & Co., Inc. | |
| 12.09.19 | A.P. Moeller - Maersk A-S (B) buy | Goldman Sachs Group Inc. | |
| 12.09.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 11.09.19 | A.P. Moeller - Maersk A-S (B) buy | Jefferies & Company Inc. | |
| 09.09.19 | Novo Nordisk Outperform | Bernstein Research | |
| 09.09.19 | A.P. Moeller - Maersk A-S (B) buy | Jefferies & Company Inc. | |
| 05.09.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 02.09.19 | Novo Nordisk buy | UBS AG | |
| 30.08.19 | A.P. Moeller - Maersk A-S (B) buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 30.08.19 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 29.08.19 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 28.08.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 20.08.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 20.08.19 | A.P. Moeller - Maersk A-S (B) buy | HSBC | |
| 16.08.19 | A.P. Moeller - Maersk A-S (B) buy | Goldman Sachs Group Inc. | |
| 15.08.19 | A.P. Moeller - Maersk A-S (B) buy | Jefferies & Company Inc. | |
| 15.08.19 | A.P. Moeller - Maersk A-S (B) buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 15.08.19 | A.P. Moeller - Maersk A-S (B) buy | Goldman Sachs Group Inc. | |
| 12.08.19 | Novo Nordisk Outperform | Credit Suisse Group | |
| 12.08.19 | Novo Nordisk Hold | Deutsche Bank AG | |
| 12.08.19 | Novo Nordisk Reduce | HSBC | |
| 12.08.19 | A.P. Moeller - Maersk A-S (B) buy | Goldman Sachs Group Inc. | |
| 09.08.19 | Novo Nordisk Equal weight | Barclays Capital | |
| 09.08.19 | Novo Nordisk buy | UBS AG | |
| 09.08.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 09.08.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 08.08.19 | A.P. Moeller - Maersk A-S (B) neutral | Morgan Stanley | |
| 06.08.19 | Novo Nordisk Equal-Weight | Morgan Stanley | |
| 05.08.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 31.07.19 | Novo Nordisk buy | UBS AG | |
| 08.07.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 08.07.19 | Novo Nordisk Hold | Deutsche Bank AG | |
| 08.07.19 | A.P. Moeller - Maersk A-S (B) Neutral | Goldman Sachs Group Inc. | |
| 04.07.19 | Novo Nordisk Conviction Buy | Goldman Sachs Group Inc. | |
| 28.06.19 | A.P. Moeller - Maersk A-S (B) Hold | Deutsche Bank AG | |
| 20.06.19 | Novo Nordisk Hold | Deutsche Bank AG | |
| 18.06.19 | Novo Nordisk buy | UBS AG |